Audio recording of the Company's Investor Call discussing about the audited financial results for the quarter / year ended on March 31, 2026, is available on the Company's website.
ZYDUSLIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Zydus Lifesciences has filed a disclosure under SEBI Listing Regulations informing investors that the audio recording of their Q4 and full year ended March 31, 2026 investor call is now available on the company's website. This is a routine regulatory compliance filing that makes the earnings call recording accessible to shareholders and analysts. The actual financial results, management commentary, and any forward-looking statements discussed during the call are contained in the linked audio file, not in this disclosure itself.
This filing is administrative in nature and does not contain new financial information. Investors wishing to understand the company's performance and management's outlook should listen to the full audio recording for substantive details on operations, margins, and strategy.